Biomarkers in Drug discovery and development


This biomarker conference throws light on the use of biomarkers in drug development which has emphasised the use of biomarkers as surrogate end points for effectiveness. Biomarkers enhances the understanding of the mechanism of action, enables the assessment of target engagement, facilitates early proof of dose focusing and increases the efficiency of early clinical development with improved quality of decision making, these concepts help in the drug discovery and development process.



 


    Related Conference of Biomarkers in Drug discovery and development

    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    February 25-26, 2026

    6th International Conference on Biomedicine & Pharmacotherapy

    Rome, Italy
    March 23-24, 2026

    29th European Biotechnology Congress

    Rome, Italy
    April 27-28, 2026

    7th Annual Congress on Biosimilars and Future Biotherapeutics

    Paris, France
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    June 29-30, 2026

    41st International Conference on Next-Gen Biotechnology and Applications

    Aix-en-Provence, France
    July 23-24, 2026

    27th Global Summit on Analytical and Bioanalytical Techniques

    Paris, France
    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany

    Biomarkers in Drug discovery and development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in